Maybe I'm missing something but I don't see how this can affect subjective data either. Unless all participants, both iPPS and Placebo, are in the same room and being dosed together and can compare affects (which they are not and cannot), they still do not know which dose they have received.
research reports and media, page-1554
-
- There are more pages in this discussion • 2,684 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.005(1.67%) |
Mkt cap ! $106.6M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 31.5¢ | 29.5¢ | $152.7K | 501.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16864 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 20426 | 2 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |